Charlotte M Mosterd

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Placebo Controlled

Top Venues

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sjoukje van der Hoek, Jeroen V Koomen, Erik J M van Bommel, Charlotte M Mosterd, Rosalie A Scholtes, Anne C Hesp, Jasper Stevens, Daniel H van Raalte, Hiddo J Lambers Heerspink
Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes. Journal of personalized medicine 13 (5) (2023)
Rosalie A Scholtes, Anne C Hesp, Charlotte M Mosterd, Frank Geurts, Ewout J Hoorn, Daniel J Touw, Merle M Krebber, Jaap A Joles, Hiddo J Lambers Heerspink, Daniel H van Raalte
Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes. Circulation 146 (24) (2022)
Rosalie A Scholtes, Anne C Hesp, Charlotte M Mosterd, Frank Geurts, Ewout J Hoorn, Daniel J Touw, Merle M Krebber, Jaap A Joles, Hiddo J Lambers Heerspink, Daniel H van Raalte
Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes. Circulation 146 (24) (2022)
Rosalie A Scholtes, Anne C Hesp, Charlotte M Mosterd, Frank Geurts, Ewout J Hoorn, Daniel J Touw, Merle M Krebber, Jaap A Joles, Hiddo J Lambers Heerspink, Daniel H van Raalte
Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes. Circulation 146 (24) (2022)